CK

Chintalacheruvu Keerthana

Active Director Director DIN 11362949
DIN 11362949 First appointment Oct 2025 Primary industry Consumer Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chintalacheruvu Keerthana

Data last updated:

Chintalacheruvu Keerthana is a Director at Clinsera Clinical Research Private Limited (since 2025). The company operates in Consumer Services.

DIN 11362949
Primary Designation Director
Industry Consumer Services
First Appointment 31 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Oct 20252025Active

Board colleagues of Chintalacheruvu Keerthana

Directorship timeline

Open interactive timeline →
Clinsera Clinical Research Private Limited
Premium access

Shareholding and investment profile for Chintalacheruvu Keerthana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintalacheruvu Keerthana

Chintalacheruvu Keerthana currently holds 1 directorship: Clinsera Clinical Research Private Limited (Director, since 31 Oct 2025).

Chintalacheruvu Keerthana was first appointed on 31 Oct 2025 as Director at Clinsera Clinical Research Private Limited.

The current boards of Chintalacheruvu Keerthana's companies include Chintalacheruvu Prem Kumar (Clinsera Clinical Research Private Limited), Chintalacheruvu Santhi (Clinsera Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available